Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase (Q28572367)

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Evidence for the occurrence of membrane-type serine protease 1/matriptase on the basolateral sides of enterocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

A role for membrane-type serine protease (MT-SP1) in intestinal epithelial turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Characterization of matriptase expression in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

The Met pathway: master switch and drug target in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Targeting urokinase-type plasminogen activator and its receptor for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Matrix metalloproteinases and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Activation of human meprin-alpha in a cell culture model of colorectal cancer is triggered by the plasminogen-activating system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Meprin metalloprotease expression and regulation in kidney, intestine, urinary tract infections and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

The Activation of Matriptase Requires Its Noncatalytic Domains, Serine Protease Domain, and Its Cognate Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

A slow-tight binding inhibitor of dopamine beta-monooxygenase: a transition state analogue for the product release step

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Bovine proenteropeptidase is activated by trypsin, and the specificity of enteropeptidase depends on the heavy chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

LDL-receptor structure. Calcium cages, acid baths and recycling receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

Kinetics of factor Xa inhibition by recombinant tick anticoagulant peptide: both active site and exosite interactions are required for a slow- and tight-binding inhibition mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

The alpha 2-macroglobulin receptor and epithelial glycoprotein-330: two giant receptors mediating endocytosis of multiple ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709073200

21 January 2018

Identifiers

DOI

10.1074/JBC.M709073200

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1316548

OpenCitations bibliographic resource ID

1316548

1 reference